Bristol-Myers Squibb Company (BMY) · page 153 of 197
The slide uses a precedent (Amgen) to argue for a specific operational strategy at the target company (Bristol-Myers).
Activist deck · peer_benchmark · compare_peers · dense density
Slide locked Sign in to view
Slide schematic 6/6
chart 2/2 paragraph 1/1 source-note 1/1 title 2/2
Components 6
bar-vertical bar-vertical paragraph source-note action-title headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1